Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HONE
2426
DELISTED
HarborOne Bancorp
HONE
| $3.74M | ﹤0.01% |
312,032
-3,769
| -1% | -$40.2K |
|
2427
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.74B
| $3.73M | ﹤0.01% |
50,877
-9,261
| -15% | -$612K |
|
2428
DocGo
DCGO
$37.7M
| $3.73M | ﹤0.01% |
667,852
+21,210
| +3% | +$122K |
|
2429
Adaptive Biotechnologies
ADPT
$4.42B
| $3.7M | ﹤0.01% |
755,932
-103,135
| -12% | -$471K |
|
|
EWCZ
2430
DELISTED
European Wax Center
EWCZ
| $3.69M | ﹤0.01% |
271,836
+3,419
| +1% | +$49.5K |
|
2431
Grab
GRAB
$11.7B
| $3.69M | ﹤0.01% |
1,096,172
-63,726
| -5% | -$206K |
|
2432
Pulmonx
LUNG
$83.7M
| $3.69M | ﹤0.01% |
289,357
+4,275
| +1% | +$44.5K |
|
2433
Maravai LifeSciences
MRVI
$1.02B
| $3.69M | ﹤0.01% |
562,674
-47,512
| -8% | -$307K |
|
|
LL
2434
DELISTED
LL Flooring Holdings, Inc.
LL
| $3.68M | ﹤0.01% |
944,795
+318,125
| +51% | +$1.06M |
|
2435
Planet Labs
PL
$5.83B
| $3.68M | ﹤0.01% |
1,489,722
+73,245
| +5% | +$173K |
|
2436
Fate Therapeutics
FATE
$292M
| $3.68M | ﹤0.01% |
983,019
+96,304
| +11% | +$227K |
|
|
TELL
2437
DELISTED
Tellurian Inc.
TELL
| $3.67M | ﹤0.01% |
4,861,810
+499,672
| +11% | +$354K |
|
2438
First Watch Restaurant Group
FWRG
$644M
| $3.67M | ﹤0.01% |
182,395
+2,330
| +1% | +$42K |
|
2439
United States Lime & Minerals
USLM
$3.27B
| $3.66M | ﹤0.01% |
79,535
+735
| +0.9% | +$31.1K |
|
|
FFIC
2440
DELISTED
Flushing Financial
FFIC
| $3.66M | ﹤0.01% |
221,848
+2,339
| +1% | +$32.6K |
|
2441
Tango Therapeutics
TNGX
$3.94B
| $3.65M | ﹤0.01% |
369,066
+1,709
| +0.5% | +$14.8K |
|
2442
Novavax
NVAX
$1.54B
| $3.65M | ﹤0.01% |
760,333
+56,983
| +8% | +$349K |
|
2443
First Financial Corp
THFF
$914M
| $3.65M | ﹤0.01% |
84,790
+531
| +0.6% | +$19.8K |
|
2444
Edgewise Therapeutics
EWTX
$4.93B
| $3.62M | ﹤0.01% |
331,059
+200
| +0.1% | +$1.4K |
|
2445
U-Haul Holding Co
UHAL
$12.3B
| $3.62M | ﹤0.01% |
50,424
+1,742
| +4% | +$98.8K |
|
2446
Turning Point Brands
TPB
$1.41B
| $3.61M | ﹤0.01% |
137,247
+4,712
| +4% | +$108K |
|
2447
Applied Digital
APLD
$6.93B
| $3.6M | ﹤0.01% |
534,700
+50,042
| +10% | +$269K |
|
|
LUCK
2448
Lucky Strike Entertainment
LUCK
$728M
| $3.6M | ﹤0.01% |
254,392
-52,857
| -17% | -$580K |
|
2449
Arrow Financial
AROW
$708M
| $3.6M | ﹤0.01% |
128,918
+1,818
| +1% | +$42.4K |
|
|
ONL
2450
Orion Office REIT
ONL
$139M
| $3.58M | ﹤0.01% |
626,014
+184,223
| +42% | +$961K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.